table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Radiopharmaceuticals for Therapeutic Market Size Analysis from 2022 to 2027
1.5.1 Global Radiopharmaceuticals for Therapeutic Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Radiopharmaceuticals for Therapeutic Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Radiopharmaceuticals for Therapeutic Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Radiopharmaceuticals for Therapeutic Industry Impact
Chapter 2 Global Radiopharmaceuticals for Therapeutic Competition by Types, Applications, and Top Regions and Countries
2.1 Global Radiopharmaceuticals for Therapeutic (Volume and Value) by Type
2.1.1 Global Radiopharmaceuticals for Therapeutic Consumption and Market Share by Type (2016-2021)
2.1.2 Global Radiopharmaceuticals for Therapeutic Revenue and Market Share by Type (2016-2021)
2.2 Global Radiopharmaceuticals for Therapeutic (Volume and Value) by Application
2.2.1 Global Radiopharmaceuticals for Therapeutic Consumption and Market Share by Application (2016-2021)
2.2.2 Global Radiopharmaceuticals for Therapeutic Revenue and Market Share by Application (2016-2021)
2.3 Global Radiopharmaceuticals for Therapeutic (Volume and Value) by Regions
2.3.1 Global Radiopharmaceuticals for Therapeutic Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Radiopharmaceuticals for Therapeutic Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Radiopharmaceuticals for Therapeutic Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Radiopharmaceuticals for Therapeutic Consumption by Regions (2016-2021)
4.2 North America Radiopharmaceuticals for Therapeutic Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Radiopharmaceuticals for Therapeutic Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Radiopharmaceuticals for Therapeutic Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Radiopharmaceuticals for Therapeutic Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Radiopharmaceuticals for Therapeutic Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Radiopharmaceuticals for Therapeutic Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Radiopharmaceuticals for Therapeutic Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Radiopharmaceuticals for Therapeutic Sales, Consumption, Export, Import (2016-2021)
4.10 South America Radiopharmaceuticals for Therapeutic Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Radiopharmaceuticals for Therapeutic Market Analysis
5.1 North America Radiopharmaceuticals for Therapeutic Consumption and Value Analysis
5.1.1 North America Radiopharmaceuticals for Therapeutic Market Under COVID-19
5.2 North America Radiopharmaceuticals for Therapeutic Consumption Volume by Types
5.3 North America Radiopharmaceuticals for Therapeutic Consumption Structure by Application
5.4 North America Radiopharmaceuticals for Therapeutic Consumption by Top Countries
5.4.1 United States Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
5.4.2 Canada Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
5.4.3 Mexico Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
Chapter 6 East Asia Radiopharmaceuticals for Therapeutic Market Analysis
6.1 East Asia Radiopharmaceuticals for Therapeutic Consumption and Value Analysis
6.1.1 East Asia Radiopharmaceuticals for Therapeutic Market Under COVID-19
6.2 East Asia Radiopharmaceuticals for Therapeutic Consumption Volume by Types
6.3 East Asia Radiopharmaceuticals for Therapeutic Consumption Structure by Application
6.4 East Asia Radiopharmaceuticals for Therapeutic Consumption by Top Countries
6.4.1 China Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
6.4.2 Japan Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
6.4.3 South Korea Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
Chapter 7 Europe Radiopharmaceuticals for Therapeutic Market Analysis
7.1 Europe Radiopharmaceuticals for Therapeutic Consumption and Value Analysis
7.1.1 Europe Radiopharmaceuticals for Therapeutic Market Under COVID-19
7.2 Europe Radiopharmaceuticals for Therapeutic Consumption Volume by Types
7.3 Europe Radiopharmaceuticals for Therapeutic Consumption Structure by Application
7.4 Europe Radiopharmaceuticals for Therapeutic Consumption by Top Countries
7.4.1 Germany Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
7.4.2 UK Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
7.4.3 France Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
7.4.4 Italy Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
7.4.5 Russia Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
7.4.6 Spain Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
7.4.7 Netherlands Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
7.4.8 Switzerland Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
7.4.9 Poland Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
Chapter 8 South Asia Radiopharmaceuticals for Therapeutic Market Analysis
8.1 South Asia Radiopharmaceuticals for Therapeutic Consumption and Value Analysis
8.1.1 South Asia Radiopharmaceuticals for Therapeutic Market Under COVID-19
8.2 South Asia Radiopharmaceuticals for Therapeutic Consumption Volume by Types
8.3 South Asia Radiopharmaceuticals for Therapeutic Consumption Structure by Application
8.4 South Asia Radiopharmaceuticals for Therapeutic Consumption by Top Countries
8.4.1 India Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
8.4.2 Pakistan Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Radiopharmaceuticals for Therapeutic Market Analysis
9.1 Southeast Asia Radiopharmaceuticals for Therapeutic Consumption and Value Analysis
9.1.1 Southeast Asia Radiopharmaceuticals for Therapeutic Market Under COVID-19
9.2 Southeast Asia Radiopharmaceuticals for Therapeutic Consumption Volume by Types
9.3 Southeast Asia Radiopharmaceuticals for Therapeutic Consumption Structure by Application
9.4 Southeast Asia Radiopharmaceuticals for Therapeutic Consumption by Top Countries
9.4.1 Indonesia Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
9.4.2 Thailand Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
9.4.3 Singapore Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
9.4.4 Malaysia Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
9.4.5 Philippines Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
9.4.6 Vietnam Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
9.4.7 Myanmar Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
Chapter 10 Middle East Radiopharmaceuticals for Therapeutic Market Analysis
10.1 Middle East Radiopharmaceuticals for Therapeutic Consumption and Value Analysis
10.1.1 Middle East Radiopharmaceuticals for Therapeutic Market Under COVID-19
10.2 Middle East Radiopharmaceuticals for Therapeutic Consumption Volume by Types
10.3 Middle East Radiopharmaceuticals for Therapeutic Consumption Structure by Application
10.4 Middle East Radiopharmaceuticals for Therapeutic Consumption by Top Countries
10.4.1 Turkey Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
10.4.3 Iran Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
10.4.5 Israel Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
10.4.6 Iraq Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
10.4.7 Qatar Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
10.4.8 Kuwait Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
10.4.9 Oman Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
Chapter 11 Africa Radiopharmaceuticals for Therapeutic Market Analysis
11.1 Africa Radiopharmaceuticals for Therapeutic Consumption and Value Analysis
11.1.1 Africa Radiopharmaceuticals for Therapeutic Market Under COVID-19
11.2 Africa Radiopharmaceuticals for Therapeutic Consumption Volume by Types
11.3 Africa Radiopharmaceuticals for Therapeutic Consumption Structure by Application
11.4 Africa Radiopharmaceuticals for Therapeutic Consumption by Top Countries
11.4.1 Nigeria Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
11.4.2 South Africa Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
11.4.3 Egypt Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
11.4.4 Algeria Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
11.4.5 Morocco Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
Chapter 12 Oceania Radiopharmaceuticals for Therapeutic Market Analysis
12.1 Oceania Radiopharmaceuticals for Therapeutic Consumption and Value Analysis
12.2 Oceania Radiopharmaceuticals for Therapeutic Consumption Volume by Types
12.3 Oceania Radiopharmaceuticals for Therapeutic Consumption Structure by Application
12.4 Oceania Radiopharmaceuticals for Therapeutic Consumption by Top Countries
12.4.1 Australia Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
12.4.2 New Zealand Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
Chapter 13 South America Radiopharmaceuticals for Therapeutic Market Analysis
13.1 South America Radiopharmaceuticals for Therapeutic Consumption and Value Analysis
13.1.1 South America Radiopharmaceuticals for Therapeutic Market Under COVID-19
13.2 South America Radiopharmaceuticals for Therapeutic Consumption Volume by Types
13.3 South America Radiopharmaceuticals for Therapeutic Consumption Structure by Application
13.4 South America Radiopharmaceuticals for Therapeutic Consumption Volume by Major Countries
13.4.1 Brazil Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
13.4.2 Argentina Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
13.4.3 Columbia Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
13.4.4 Chile Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
13.4.5 Venezuela Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
13.4.6 Peru Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
13.4.8 Ecuador Radiopharmaceuticals for Therapeutic Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Radiopharmaceuticals for Therapeutic Business
14.1 Bayer
14.1.1 Bayer Company Profile
14.1.2 Bayer Radiopharmaceuticals for Therapeutic Product Specification
14.1.3 Bayer Radiopharmaceuticals for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Novartis
14.2.1 Novartis Company Profile
14.2.2 Novartis Radiopharmaceuticals for Therapeutic Product Specification
14.2.3 Novartis Radiopharmaceuticals for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 China Isotope & Radiation
14.3.1 China Isotope & Radiation Company Profile
14.3.2 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product Specification
14.3.3 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Dongcheng
14.4.1 Dongcheng Company Profile
14.4.2 Dongcheng Radiopharmaceuticals for Therapeutic Product Specification
14.4.3 Dongcheng Radiopharmaceuticals for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Q BioMed
14.5.1 Q BioMed Company Profile
14.5.2 Q BioMed Radiopharmaceuticals for Therapeutic Product Specification
14.5.3 Q BioMed Radiopharmaceuticals for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Curium Pharmaceuticals
14.6.1 Curium Pharmaceuticals Company Profile
14.6.2 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Specification
14.6.3 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Jubilant DraxImage
14.7.1 Jubilant DraxImage Company Profile
14.7.2 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Product Specification
14.7.3 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Lantheus
14.8.1 Lantheus Company Profile
14.8.2 Lantheus Radiopharmaceuticals for Therapeutic Product Specification
14.8.3 Lantheus Radiopharmaceuticals for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Spectrum Pharmaceuticals
14.9.1 Spectrum Pharmaceuticals Company Profile
14.9.2 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Specification
14.9.3 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Progenics Pharmaceuticals
14.10.1 Progenics Pharmaceuticals Company Profile
14.10.2 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Specification
14.10.3 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 International Isotopes
14.11.1 International Isotopes Company Profile
14.11.2 International Isotopes Radiopharmaceuticals for Therapeutic Product Specification
14.11.3 International Isotopes Radiopharmaceuticals for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Radiopharmaceuticals for Therapeutic Market Forecast (2022-2027)
15.1 Global Radiopharmaceuticals for Therapeutic Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Radiopharmaceuticals for Therapeutic Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Radiopharmaceuticals for Therapeutic Value and Growth Rate Forecast (2022-2027)
15.2 Global Radiopharmaceuticals for Therapeutic Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Radiopharmaceuticals for Therapeutic Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Radiopharmaceuticals for Therapeutic Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Radiopharmaceuticals for Therapeutic Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Radiopharmaceuticals for Therapeutic Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Radiopharmaceuticals for Therapeutic Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Radiopharmaceuticals for Therapeutic Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Radiopharmaceuticals for Therapeutic Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Radiopharmaceuticals for Therapeutic Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Radiopharmaceuticals for Therapeutic Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Radiopharmaceuticals for Therapeutic Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Radiopharmaceuticals for Therapeutic Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Radiopharmaceuticals for Therapeutic Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Radiopharmaceuticals for Therapeutic Consumption Forecast by Type (2022-2027)
15.3.2 Global Radiopharmaceuticals for Therapeutic Revenue Forecast by Type (2022-2027)
15.3.3 Global Radiopharmaceuticals for Therapeutic Price Forecast by Type (2022-2027)
15.4 Global Radiopharmaceuticals for Therapeutic Consumption Volume Forecast by Application (2022-2027)
15.5 Radiopharmaceuticals for Therapeutic Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
